2024 Annual Meeting | SS11 - AAN Section Spotlight: Monoclonal Antibodies in Clinical Practice

Date Tuesday 04/16/24

Time 04:30 PM - 05:30 PM MDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Other

Director(s) Gregory E. Cooper, MD, PhD, FAAN, Glen R. Finney, MD, FAAN, Cara B. Leahy, DO, Anitha Rao, MD

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Sponsored by the Geriatric Section.

CME Available 0.00 CME credit

Event Timeline
04:30 PM - 05:30 PM MDT	Discussion	AAN Section Spotlight: Monoclonal Antibodies in Clinical Practice Gregory E. Cooper, MD, PhD, FAAN, Glen R. Finney, MD, FAAN, Cara B. Leahy, DO, Anitha Rao, MD

Faculty Disclosures
Gregory E. Cooper, MD, PhD, FAAN	The institution of Dr. Cooper has received research support from Eli Lilly. The institution of Dr. Cooper has received research support from Davos Alzheimer's Collaborative. The institution of Dr. Cooper has received research support from Eisai. Dr. Cooper has a non-compensated relationship as a Consultant with Health & Wellness Partners, LLC that is relevant to AAN interests or activities.
Glen R. Finney, MD, FAAN	Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities.
Cara B. Leahy, DO	No disclosure on file
Anitha Rao, MD	An immediate family member of Dr. Rao has received personal compensation for serving as an employee of Abbvie. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurovision. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Virtusense. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. An immediate family member of Dr. Rao has stock in Abbvie. Dr. Rao has a non-compensated relationship as a Executive Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities.

��ɫ����